Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes

BACKGROUND: The FIDELIO-DKD trial (Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease) evaluated the effect of the nonsteroidal, selective mineralocorticoid receptor antagonist finerenone on kidney and cardiovascular outcomes in patients with chronic kidney dise...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Circulation
Main Authors: Filippatos, Gerasimos, Anker, Stefan D., Agarwal, Rajiv, Pitt, Bertram, Ruilope, Luis M., Rossing, Peter, Kolkhof, Peter, Schloemer, Patrick, Tornus, Ingo, Joseph, Amer, Bakris, George L.
Format: Artigo
Sprog:Inglês
Udgivet: Lippincott Williams & Wilkins 2020
Fag:
Original Research Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7864612/
https://ncbi.nlm.nih.gov/pubmed/33198491
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.120.051898
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker